Pilot Pen G2 Edge


CVS exceeds predictions for quarter

WOONSOCKET, R.I. — CVS Health posted first quarter sales and earnings that beat Wall Street forecasts. Revenue for the period through March 31 increased 11% to $85.3 billion, exceeding analysts’ projection of $80.8 billion. Adjusted earnings of $2.20 per share topped the average estimate of $2.09. The company lowered its outlook for the full year,

CVS, Walgreens limiting purchases of kids’ pain and fever medicines

CVS, Walgreens limiting purchases of kids’ pain and fever medicines

NEW YORK — Both CVS and Walgreens said they are limiting how many children’s pain and fever medications customers can buy — the latest sign that pharmacies are struggling to keep up with demand for basic cold and flu remedies, as respiratory illnesses spike nationwide. CVS is limiting customers to a “two product limit on

CVS, Walgreens settle opioid lawsuits

NEW YORK — CVS and Walgreens said this month they had reached tentative agreements to pay nearly $5 billion each to settle lawsuits over their roles in the opioid crisis. If completed, the deals would hasten the end of thousands of lawsuits in which state, local iiand tribal governments claimed pharmacies filled prescriptions that should

CVS beats Q3 sales, earnings forecasts

WOONSOCKET, R.I. — CVS Health easily beat analysts’ sales and earnings estimates for the third quarter and again raised its full-year guidance. The company reported adjusted earnings per share of $2.09 on revenue of $81.16 billion, which climbed 10% from a year earlier. Wall Street had expected adjusted EPS of $1.99 on revenue of $76.75

1 2 3 5